U.S. Medical Equipment Stock News

NYSE:UBER
NYSE:UBERTransportation

Uber (UBER) Builds A 30 Partner Autonomous Vehicle Network Across Rides And Delivery

Uber Technologies (NYSE:UBER) has built a broad network of more than 30 global partnerships and investments in autonomous vehicle companies. These collaborations involve firms such as Aurora, Lucid Motors, Nvidia, Baidu, and WeRide across both ride hailing and delivery use cases. Thousands of robotaxis and autonomous delivery vehicles are already operating in multiple cities through these relationships. Uber Technologies has moved well beyond testing self driving concepts and is building a...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Why Rezolve AI (RZLV) Is Up 11.3% After Raising 2026 Outlook And Partnering With Zilch

In July 2026, Rezolve AI PLC projected approximately US$127 million of first-half 2026 revenue and reaffirmed full-year 2026 guidance of about US$360 million, while also entering a partnership to embed its Reward platform into Zilch’s payments experience for nearly 6 million customers. The combination of sharply higher revenue expectations and integration into a high-traffic payments platform underscores Rezolve AI’s push to become core infrastructure for AI-enabled commerce across financial...
NYSE:WCC
NYSE:WCCTrade Distributors

Why WESCO International (WCC) Is Up 9.3% After Strong Q2 Results And Data Center Expansion Plans

WESCO International, Inc. recently reported its second quarter and first half 2026 results, showing higher sales of US$6,665.1 million for the quarter and US$12,745.2 million for the half year, alongside increased net income and earnings per share compared with the same periods a year ago. During the earnings call, management also highlighted its Power-to-Compute model and plans to pursue organic investments and targeted bolt-on acquisitions to expand its role across the full data center...
NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Diodes (DIOD) Stock May Be Cheap As Earnings Keep Supporting Value

Diodes stock has delivered a strong 66.8% return over the past year, yet its low value score and an earnings based view that screens as undervalued leave investors with mixed signals about how much margin of safety is really on offer at around US$82 per share. Over the last 12 months, Diodes is up 66.8%, which puts recent holders in a strong position and raises the question of how much of the good news is already in the price. Expectations for the company to keep generating solid earnings...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Posted Strong Q2 Results, Is It Still A Bargain?

Mastercard (MA) just posted second quarter results that put fresh numbers around its growth story. Revenue reached US$9,277 million and net income came in at US$4,388 million, supported by ongoing share buybacks. See our latest analysis for Mastercard. The latest earnings release and new partnerships in travel, expense and stablecoin infrastructure have kept Mastercard in focus. The share price is at US$570.97 with a 90 day share price return of 16.08%, alongside a 3 year total shareholder...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo (MASI) Wins FDA Clearance As Fair Value Questions Return

Masimo (MASI) stock is in focus after the company received FDA 510(k) clearance for its pediatric Patient State Index sedation score, extending the SedLine brain monitoring suite to children four years and older. See our latest analysis for Masimo. The FDA clearance comes as Masimo’s share price sits at US$179.95, with a year to date share price return of 41.25% and a 1 year total shareholder return of 7.09%. This suggests momentum has picked up recently after weaker multi year total...
NYSE:HCI
NYSE:HCIInsurance

How Investors May Respond To HCI Group (HCI) Balancing Tech Ambitions With Cautious Earnings Expectations

HCI Group recently came into focus ahead of its June 2026 quarter earnings, where projections pointed to a slight year-over-year decline despite a positive Earnings ESP and a Zacks Rank of #3 (Hold). This tension between cautious earnings expectations and optimism around the company’s technology engine Exzeo and underwriting discipline has sharpened attention on its insurance and tech-driven margin story. We’ll now examine how anticipation of a possible June-quarter EPS beat reshapes HCI...
NYSE:MAIN
NYSE:MAINCapital Markets

Main Street Capital (MAIN) Stock Looks Like A Bargain On Value But Full On Earnings

Main Street Capital has almost doubled investors' money over the past five years, yet its current share price around US$55.75 sits between two conflicting signals, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples lean the other way. Main Street Capital has delivered a 93.5% total return over five years, which keeps expectations for future returns in sharper focus. Ongoing income generation from its investment portfolio can support views of...
NYSE:COP
NYSE:COPOil and Gas

What ConocoPhillips (COP)'s Pelto Island Wetlands Restoration Role Means For Shareholders

In late July 2026, CCA Louisiana announced it had completed major phases of a Pelto Island habitat restoration in partnership with ConocoPhillips, the Louisiana Department of Wildlife and Fisheries, Natrx and Danos, installing 650 ExoForm reef modules to rebuild critical speckled trout and redfish habitat. This Louisiana-built project highlights ConocoPhillips’ role as lead partner and largest private wetlands owner in the state, underscoring how coastal stewardship and community-focused...
NYSE:OVV
NYSE:OVVOil and Gas

How Investors May Respond To Ovintiv (OVV) Q2 Profit Rebound, Guidance Update And Steady Dividend

In July 2026, Ovintiv Inc. reported its second-quarter 2026 results, with revenue rising to US$3,013 million and net income to US$456 million, while also updating production guidance and confirming a US$0.30 quarterly dividend payable in late September. An interesting twist is that, despite stronger quarterly profits, Ovintiv recorded a US$174 million net loss for the first half of 2026, highlighting uneven year-to-date performance beneath the headline growth. We’ll now examine how...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum Holdings (LITE) Could Be 85% Undervalued On Coherent Led Sector Momentum

Lumentum Holdings (LITE) has attracted fresh attention after a 9.3% jump linked to sector peer Coherent and speculation about potential index inclusion that could influence institutional and technical trading flows. See our latest analysis for Lumentum Holdings. The recent 1 day share price return of 9.24% for Lumentum Holdings sits within a wider pattern, with a 7 day share price return of 19.63% and a 30 day share price return of 7.08%, even though the 90 day share price return is down...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Twist Bioscience (TWST) Stock Rally Faces Pressure From Fresh Losses

Twist Bioscience stock came into this earnings print already heated after a strong run over the past quarter. The market pushed the share price up another 10.4% to about US$101 by the close after Q3 numbers hit. That kind of one day move suggests emotion may be in the driver’s seat. The key focus today is revenue momentum. Twist Bioscience reported Q3 revenue of US$118.4m and raised full year sales guidance to a range of US$456m to US$457m. At the same time the company is still reporting...
NasdaqGS:STEP
NasdaqGS:STEPCapital Markets

StepStone Group (STEP) Looks Above Fair Value Following A 6% Sector Rally

StepStone Group (STEP) moved higher alongside a sector wide rally in asset managers, with the stock gaining 6.0% as institutional buyers returned to alternative asset management and sentiment around fundraising and deployment improved. See our latest analysis for StepStone Group. At a share price of US$46.59, StepStone Group has seen a 13.28% 1 month share price return and a decline of 30.06% year to date, while the 3 year total shareholder return of 76.34% points to longer term investors...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Supernus Pharmaceuticals (SUPN) Stock Rebounds As Revenue Growth Meets Profit Crunch

Supernus Pharmaceuticals stock climbed about 3% to roughly US$46, even as the company reported another quarterly loss. The headline this quarter is not the revenue line, which reached about US$219 million. The real story is the sharp hit to profitability, with basic earnings per share swinging to a loss of about US$1.01 and net income showing a loss of roughly US$58 million. For investors, today’s modest bounce comes against a backdrop of pressure on margins and a trailing twelve month loss...
NYSE:KEX
NYSE:KEXShipping

Kirby (KEX) Misses Earnings Estimates, Is The Stock 22% Undervalued?

Kirby (KEX) is back in focus after its second quarter 2026 earnings came in below analyst expectations, as higher fuel costs and shipyard activity pressured margins despite firm marine demand and reaffirmed full year earnings guidance. See our latest analysis for Kirby. Kirby’s latest earnings miss and reaffirmed guidance have come alongside a share price that has eased in the short term, with a 7 day share price return down 10.22%, while the year to date share price return of 16.65% and 1...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Could Be 63% Undervalued On BlueBird Launch And Rakuten Progress

AST SpaceMobile (ASTS) is back in focus after scheduling the August 5 launch of its BlueBird 11, 12 and 13 satellites, as well as reporting progress on a direct-to-cell partnership with Rakuten Mobile in Japan. See our latest analysis for AST SpaceMobile. These launch and partnership updates come after a mixed period for AST SpaceMobile's stock. The share price is up 7.7% over the last day and 12.3% over the week, yet down 25.4% over the past month and 23.9% year to date. Total shareholder...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart Holdings (UPST) Is Up 5.8% After $4 Billion Loan Pact And Conditional Bank Approval

In late July 2026, Upstart Holdings, Inc. announced its largest program to date with Castlelake-managed funds agreeing to purchase up to US$4.00 billion of consumer loans over up to 24 months through a new forward-flow arrangement. Within days of that capital commitment, Upstart also received conditional approval from the Office of the Comptroller of the Currency to form a nationwide, AI-driven digital bank that could ultimately centralize its lending and deposit operations once all...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Appoints Luca Santandrea To Lead Poland And Baltic Markets

Coca-Cola (NYSE:KO) has appointed Luca Santandrea as General Director for Poland and the Baltic markets. The new leadership role covers Poland, Lithuania, Latvia, and Estonia, which are meaningful international markets for the company. This appointment highlights a management shift in a region where Coca-Cola is focused on business integration and operational development. Coca-Cola comes into this leadership change with the stock at $86.86 and multi year returns of 25.7% year to date and...
NYSE:ADT
NYSE:ADTConsumer Services

Is ADT (ADT) Still Below Fair Value As Raised Guidance Lifts Expectations?

ADT (ADT) drew fresh investor attention after raising its full year 2026 earnings guidance, alongside second quarter results that showed steady revenue and net income trends, a completed buyback and an affirmed dividend. See our latest analysis for ADT. The raised 2026 earnings guidance and sizeable completed buyback appear to have reset expectations around ADT, with the stock posting a 15.37% 1 month share price return and a 36.17% 3 year total shareholder return, despite a slightly weaker...
NYSE:PM
NYSE:PMTobacco

Philip Morris International (PM) Could Be 3% Below Fair Value After Brazil Lawsuit Progress

Philip Morris International (PM) stock is in focus after a landmark Brazilian lawsuit targeting cigarette makers reached a key procedural milestone. All legal submissions are now complete, and the case is awaiting a liability ruling. See our latest analysis for Philip Morris International. Philip Morris International’s recent 1-day share price decline of 1.79% and 7-day fall of 6.37% sit against a stronger backdrop, with a 30-day share price return of 2.82%, a 90-day gain of 9.90%, and a...
NYSE:BCO
NYSE:BCOCommercial Services

Brink's (BCO) Stock May Be Undervalued On Its Earnings Power

Brink's stock has delivered a 63.1% return over the past three years, yet its current valuation signals present a mixed picture, with the shares screening as undervalued on market multiples but only partly supported by broader valuation checks. Brink's 63.1% return over three years points to solid shareholder gains that now need to be weighed against how much value is already reflected in the price. Expectations around Brink's ability to sustain cash generation from its security and...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

WaFd (WAFD) Tests Its Build 2030 Story As Valuation Looks Close To Fair Value

WaFd (WAFD) is back in focus after recent trading left the stock at US$37.36, with short term moves mixed. Investors are now weighing the bank’s fundamentals and valuation at this price. See our latest analysis for WaFd. Recent trading has been mixed for WaFd, with a 1 day share price return of 1.6% helping to offset a 1 month share price return that fell 2.6%. At the same time, the year to date share price return of 16.3% and 1 year total shareholder return of 30.0% indicate that momentum...
NYSE:ESTC
NYSE:ESTCSoftware

Why Elastic (ESTC) Is Up 10.7% After Deepening Its OpenAI Integration For Governed AI Workflows

In late July 2026, Elastic N.V. announced an expanded collaboration with OpenAI to integrate OpenAI’s advanced reasoning models with Elasticsearch for enterprise-ready AI agents, observability, and security operations, while also extending AI governance and cyber capabilities through OpenAI’s Daybreak Cyber Partner Program. An interesting angle is that Elastic is positioning itself as the governed retrieval and observability layer for OpenAI-powered enterprise workflows, potentially...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Will Intuitive’s Drape Recall and Bylaw Shift Reshape Intuitive Surgical’s (ISRG) Risk Management Narrative?

In July 2026, Intuitive Surgical amended its bylaws and faced an FDA enforcement report on an ongoing, voluntary Class II recall of da Vinci SP Instrument Arm Drapes affecting more than 11,000 units distributed across the US and multiple international markets. These governance changes and the recall highlight how Intuitive manages shareholder influence and product quality risks in a complex, global medtech business. We’ll now examine how the da Vinci SP drape recall, including its potential...